Safety and Drug Comparison Study in Healthy Adults
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests new experimental medications (ATB-U101 and related compounds) in healthy volunteers to understand how the body processes them and confirm they are safe. Researchers compare different versions to find the best formulation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 64 years old
- You are in good overall health with no serious medical conditions
- Your weight is between 110 and 214 pounds, and your BMI is between 18 and 30
- You do not have genetic conditions affecting sugar digestion (galactose intolerance, lactase deficiency, or glucose-galactose malabsorption)
- You test negative for hepatitis B, hepatitis C, HIV, and syphilis
- Your ancestry is primarily European, North American, or Middle Eastern, with less than 10 years lifetime residence outside those regions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
This trial tests the safety and how the body processes three common diabetes medications (dapagliflozin, linagliptin, and metformin) when taken together. Healthy volunteers are needed to help researchers understand how these drugs work in the body.
This study tests how the body handles three diabetes medicines (dapagliflozin, linagliptin, and metformin) when taken with food. It is for healthy volunteers to check safety and drug levels.
This trial tests a new medicine, UBT251, to see how well it lowers blood sugar in people with type 2 diabetes. It compares different doses to find the best one for you.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.